{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:04Z","timestamp":1790380804617,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.labinv.2026.106144","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:02:43Z","timestamp":1781222563000},"page":"106144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analytical Sensitivity and HER2-Low: To Measure or Not to Measure, That Is the Question"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-9804","authenticated-orcid":false,"given":"Emina Emilia","family":"Torlakovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.labinv.2026.106144_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2026.106136","article-title":"Immunohistochemical assay variability and human epidermal growth factor receptor 2 (HER2)-Low breast cancer detection: a laboratory comparison in the Netherlands","volume":"106","author":"Kain","year":"2026","journal-title":"Lab Invest"},{"key":"10.1016\/j.labinv.2026.106144_bib2","article-title":"HER2-low breast cancer in routine practice: a nationwide study of diagnostic variability across pathology laboratories","author":"Kain","year":"2025","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.labinv.2026.106144_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11095-005-9045-3","article-title":"Fit-for-purpose method development and validation for successful biomarker measurement","volume":"23","author":"Lee","year":"2006","journal-title":"Pharm Res"},{"issue":"6943","key":"10.1016\/j.labinv.2026.106144_bib4","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1136\/bmj.308.6943.1552","article-title":"Diagnostic tests. 1: sensitivity and specificity","volume":"308","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.labinv.2026.106144_bib5","series-title":"Protocols for Determination of Limits of Detection and Limits of Quantitation. 1st ed. CLSI guideline EP17-A","year":"2004"},{"issue":"7","key":"10.1016\/j.labinv.2026.106144_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5858\/arpa.2017-0330-OA","article-title":"Quantitative assessment of immunohistochemistry laboratory performance by measuring analytic response curves and limits of detection","volume":"142","author":"Sompuram","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAI.0000000000000163","article-title":"Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee","volume":"23","author":"Torlakovic","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7326\/0003-4819-126-1-199701010-00026","article-title":"\u201cSensitivity\u201d and \u201cspecificity\u201d reconsidered: the meaning of these terms in analytical and diagnostic settings","volume":"126","author":"Saah","year":"1997","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.labinv.2026.106144_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/C6LC00015K","article-title":"Translating diagnostic assays from the laboratory to the clinic: analytical and clinical metrics for device development and evaluation","volume":"16","author":"Borysiak","year":"2016","journal-title":"Lab Chip"},{"issue":"2","key":"10.1016\/j.labinv.2026.106144_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/PAS.0b013e3181238cec","article-title":"A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors","volume":"32","author":"Espinosa","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.labinv.2026.106144_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00428-025-04169-4","article-title":"Indirect clinical validation for predictive biomarkers in oncology: International Quality Network for Pathology (IQN Path) Position Paper","volume":"487","author":"Torlakovic","year":"2025","journal-title":"Virchows Arch"},{"issue":"21","key":"10.1016\/j.labinv.2026.106144_bib12","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non\u2013small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.labinv.2026.106144_bib13","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American Pathologists Guideline Update","volume":"41","author":"Wolff","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.labinv.2026.106144_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjp.0707441","article-title":"Biomarker method validation in anticancer drug development","volume":"153","author":"Cummings","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.labinv.2026.106144_bib15","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/1078-0432.CCR-09-2845","article-title":"A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry","volume":"16","author":"Mino-Kenudson","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.labinv.2026.106144_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/clinchem\/hvab008","article-title":"Development and validation of measurement traceability for in situ immunoassays","volume":"67","author":"Torlakovic","year":"2021","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jamaoncol.2015.3638","article-title":"Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer","volume":"2","author":"McLaughlin","year":"2016","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.labinv.2026.106144_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00428-016-1910-4","article-title":"Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients","volume":"468","author":"Ilie","year":"2016","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.labinv.2026.106144_bib20","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMoa2407086","article-title":"Trastuzumab deruxtecan after endocrine therapy in metastatic breast cancer","volume":"391","author":"Bardia","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAI.0000000000001296","article-title":"The suitability of repurposed, legacy HER2 immunohistochemistry assays for the detection of HER2 low and ultralow expression: current limitations and potential considerations","volume":"34","author":"Yaziji","year":"2026","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"10.1016\/j.labinv.2026.106144_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/curroncol33040181","article-title":"\u201cHER2-low\u201d and the challenge of repurposing legacy HER2 IHC biomarker assays","volume":"33","author":"Torlakovic","year":"2026","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100032","article-title":"Multi-institutional assessment of pathologist scoring HER2 immunohistochemistry","volume":"36","author":"Robbins","year":"2023","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.labinv.2026.106144_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104233","article-title":"Validation and prospective testing of a high-sensitivity, quantitative analytic assay for HER2 on histopathology slides","volume":"105","author":"Chan","year":"2025","journal-title":"Lab Invest"},{"key":"10.1016\/j.labinv.2026.106144_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105919","article-title":"New standards in Her2-low testing: the Casi-01 comparative methods study","volume":"120","author":"Dabbs","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104261","article-title":"Interassay comparison with digital image analysis of 4 routine human epidermal growth factor receptor 2 (HER2) immunohistochemistry assays in primary breast cancer and its metastasis","volume":"106","author":"Hempenius","year":"2026","journal-title":"Lab Invest"},{"key":"10.1016\/j.labinv.2026.106144_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d556","article-title":"Correlation in restricted ranges of data","volume":"342","author":"Bland","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.labinv.2026.106144_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyn357","article-title":"Ecological correlations and the behavior of individuals","volume":"38","author":"Robinson","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ije\/18.1.269","article-title":"Ecological bias, confounding, and effect modification","volume":"18","author":"Greenland","year":"1989","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100009","article-title":"Interobserver variation in the assessment of immunohistochemistry expression levels in HER2-negative breast cancer: can we improve the identification of low levels of HER2 expression by adjusting the criteria? An international interobserver study","volume":"36","author":"Baez-Navarro","year":"2023","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106144_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70051","article-title":"Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797)","volume":"11","author":"Parry","year":"2025","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"10.1016\/j.labinv.2026.106144_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13000-025-01624-3","article-title":"Accuracy of human epidermal growth factor receptor 2 (HER2) immunohistochemistry scoring by pathologists in breast cancer, including the HER2-low cutoff: HER2 IHC scoring concordance in breast cancer","volume":"20","author":"Wr\u00f3bel","year":"2025","journal-title":"Diagn Pathol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:14:18Z","timestamp":1790378058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683726000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0023683726000747"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106144","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical Sensitivity and HER2-Low: To Measure or Not to Measure, That Is the Question","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106136","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106144"}}